LBO — TEXOMA MEDICAL CENTER
IRR: 33.1% | MOIC: 4.17x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
33.1%
IRR
4.17x
MOIC
$98.3M
Entry EV
$258.7M
Exit EV
$50.6M
Equity Invested
Sources & Uses
S&UTotal · $98.3M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $38.2M | 38.8% | |
| Sub Debt | $9.5M | 9.7% | |
| Equity | $50.6M | 51.5% | |
| Enterprise Value | $95.5M | 97.1% | |
| Transaction Fees | $2.9M | 2.9% | |
| Total Uses | $98.3M | 100.0% |
Interpretation
INTAt 4.17x MOIC and 33.1% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $24.6M |
| Exit Ev | $258.7M |
| Net Debt At Exit | $47.7M |
| Equity At Exit | $211.0M |
| Equity Invested | $50.6M |
| Total Value Created | $160.4M |
| Value From Growth | $158.5M |
| Value From Multiple | $4.8M |
| Value From Deleveraging | 0.0% |